Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Resource allocation for HIV prevention: ethics and human rights.

Cowan E, Macklin R.

AIDS. 2013 Jul 31;27(12):1997-8. No abstract available.

PMID:
24180004
2.

Antiretroviral resource allocation for HIV prevention.

Singh JA.

AIDS. 2013 Mar 27;27(6):863-5. doi: 10.1097/QAD.0b013e32835f2b30. No abstract available.

PMID:
23698059
3.

Why vulnerable young women at risk of HIV should be prioritized for access to preexposure prophylaxis.

Singh JA.

AIDS. 2013 Jul 31;27(12):1998-9. No abstract available.

PMID:
24180005
4.

Initiating antiretrovirals in a resource-constrained setting: does one size fit all?

Wanchu A.

MedGenMed. 2005 Aug 8;7(3):67. No abstract available.

5.

"3 by 5" should be replaced by "Free by 5".

Bosch X.

Lancet Infect Dis. 2005 Feb;5(2):76. No abstract available.

PMID:
15702506
6.

Pre-exposure chemoprophylaxis (PREP) as an HIV prevention strategy.

Youle M, Wainberg MA.

J Int Assoc Physicians AIDS Care (Chic). 2003 Jul-Sep;2(3):102-5. Review.

PMID:
14556428
7.

The global reach of HIV/AIDS: science, politics, economics, and research.

Gostin LO.

Emory Int Law Rev. 2003 Spring;17(1):1-54. No abstract available.

PMID:
16180288
8.

The marriage of science and optimized HIV care in resource-limited settings.

Calmy A, Pizzocolo C, Pizarro L, Brücker G, Murphy R, Katlama C; Strategies in Resource-Limited Settings Working Group..

AIDS. 2008 Nov 12;22(17):2227-30. doi: 10.1097/QAD.0b013e32830f4c4d. No abstract available.

PMID:
18981761
9.

Five year HIV plan still on course.

[No authors listed]

J R Soc Promot Health. 2008 Sep;128(5):211. No abstract available.

PMID:
18814396
10.

Cost-effectiveness of new WHO recommendations for prevention of mother-to-child transmission of HIV in a resource-limited setting.

Shah M, Johns B, Abimiku A, Walker DG.

AIDS. 2011 May 15;25(8):1093-102. doi: 10.1097/QAD.0b013e32834670b9.

PMID:
21505317
11.

Tuberculosis in resource poor countries.

Colebunders R, Apers L, Dieltiens G, Worodria W.

BMJ. 2007 Jan 20;334(7585):105-6. No abstract available.

12.

Biomedical methods for HIV prevention: new setbacks.

Laurence J.

AIDS Read. 2008 Apr;18(4):163-4. No abstract available.

PMID:
18472438
13.

The limits of success.

[No authors listed]

Science. 2014 Jul 11;345(6193):157. doi: 10.1126/science.345.6193.157. No abstract available.

PMID:
25013059
14.

Designing an equitable strategy for allocating antiretroviral treatments.

Capron AM, Reis A.

PLoS Med. 2005 Mar;2(3):e69. No abstract available.

15.

Evaluation of 4 weeks' neonatal antiretroviral prophylaxis as a component of a prevention of mother-to-child transmission program in a resource-rich setting.

Ferguson W, Goode M, Walsh A, Gavin P, Butler K.

Pediatr Infect Dis J. 2011 May;30(5):408-12. doi: 10.1097/INF.0b013e31820614bd.

PMID:
21266939
16.

The right of children in developing countries to be born and live HIV-free.

Binagwaho A.

Health Hum Rights. 2008;10(1):149-52. No abstract available.

PMID:
20845837
17.

Heart transplantation in HIV-infected patients: more cases in Europe.

Castel MA, Pérez-Villa F, Miró JM.

J Heart Lung Transplant. 2011 Dec;30(12):1418. doi: 10.1016/j.healun.2011.07.022. No abstract available.

PMID:
21889894
18.

Human rights as a cornerstone of AIDS prevention, treatment and public health measures.

Chan R.

Ann Acad Med Singapore. 2010 Dec;39(12):934-2. No abstract available.

19.

Medicines, money and motivated health workers are key to universal access to HIV/AIDS prevention, treatment care and support.

[No authors listed]

Indian J Med Sci. 2006 Sep;60(9):392-4. No abstract available.

PMID:
17001805
20.

The importance of doing HIV research in developing countries.

Morris L, Martin DJ, Quinn TC, Chaisson RE.

Nat Med. 1998 Nov;4(11):1228-9. No abstract available.

PMID:
9809535
Items per page

Supplemental Content

Support Center